Acasia Technology, Inc.

What they do

NP Life Sciences provides classical Chinese studies education and training courses (in Chinese and English), organizes China-U.S. study tours, cultural events, art fairs, and exhibitions. Its wholly owned subsidiary, GW Health Consulting Management Inc., offers online career planning experience sharing and guidance consulting, primarily through friend referrals. The Singapore and Hong Kong subsidiaries were formed but had no business transactions in the reporting period.

Revenue drivers

• Classical Chinese studies and cultural services — Core planned business: education/training, lectures, study tours, and cultural events; in early stage, revenue historically minimal.
• GW Health Consulting (career planning consulting) — Generated $99,599 in 2023 from two customers; business limited to online career planning experience sharing and guidance consulting.
• Promotions/consulting fees and commissions — Revenues from providing promotions and consulting services to tour partners and commissions from enrollment services.

Recent performance

Revenue for 2023 was $164,621, up from $102,002 in 2022. Net loss narrowed to $2,935 in 2023 from $18,856 in 2022. Operating cash flow was negative $73,607 in 2023. Quarterly revenue was highly uneven: $30,000 (Q1), $107,099 (Q2), $17,515 (Q3), $10,007 (Q4). Cash and equivalents at year-end 2023 were $70,614, though total equity was only $16,381.

Strategy

Management plans to expand mental health consulting (offline and online) for families, individuals, and company employees, targeting Southeast Asia (South Korea, Singapore, China) and eventually health care projects, health monitoring, psychological hospitals, and aesthetic medicine. For classical Chinese studies, the company intends to build a vertically integrated set of courses, study tours, and cultural events, leveraging a cooperative relationship with Shaanxi Guojiang Cultural Industry Group Co. Ltd. It also established a Singapore subsidiary (90% owned) and a Hong Kong subsidiary to support expansion.

Risks

• Early-stage operations and minimal revenue — Revenue base is tiny (under $200K annually) and highly dependent on a few customers; GW's 2023 revenue came from only two customers.
• Negative operating cash flow — Operating cash flow was negative in three of the last four reported years (2019, 2020, 2021, 2023), with 2023 at -$73,607.
• Subsidiaries yet to generate revenue — Hong Kong and Singapore subsidiaries had no business transactions in the reporting period, so expansion plans are unproven.
• Dependence on third-party partners and referrals — Customer acquisition for GW relies mainly on friend referrals; the company also relies on cooperative partners like Guojiang China for classical Chinese studies expertise.

Outlook

Management does not provide specific forward guidance. They intend to expand the classical Chinese studies curriculum and cultural exchange programs, and develop mental health consulting services, targeting Southeast Asian markets. The company acknowledges it is an emerging company and that its operations are at a very early stage.